"...and notes that eBioscience, a private company, is expected to generate about $70 million in sales this year."
I imagine the ADO royalty only applies to the revenue generated by using MNG - is that 100% of the their total revenue? Possibly not.
Plus, wouldn't any subsequent takeover of eBioscience mean that the new owner is assigned the existing contract under the same terms and conditions?
Just speculating....
